---
schema_version: "secwatch.filing_event.v1"
accession: "0001877322-22-000019"
form_type: "8-K"
ticker: "ESAB"
cik: "0001877322"
company_name: "ESAB Corp"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:55:42.121272+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ESAB Q3 beats: core adj. EPS $0.92, raises FY core adj. EPS guidance to $4.00-$4.10

## Summary
- GAAP EPS $0.88, core adjusted diluted EPS $0.92; net income $53M from continuing ops.
- Revenue $620M (+2% reported); core organic growth 10% excluding Russia and currency.
- Core adjusted EBITDA $96M, up 5% YoY; reaffirms 2022 core organic growth 11-14%.
- Raises FY core adjusted EPS guidance to $4.00-$4.10 from $3.85-$4.05; core EBITDA narrowed to $405-415M.
- Completed Ohio Medical acquisition; gas control platform now >$400M sales with >40% gross margins.

## SEC filing metadata
- accession: 0001877322-22-000019
- form_type: 8-K
- ticker: ESAB
- cik: 0001877322
- company_name: ESAB Corp
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877322/000187732222000019/0001877322-22-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877322/000187732222000019/esab-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001877322-22-000019
- JSON: https://secwatch.observer/filing/0001877322-22-000019.json
- Plain text: https://secwatch.observer/filing/0001877322-22-000019.txt

## Key facts
- Earnings Releases
  ESAB Corp reported third quarter of 2022 results: revenue $620 million, net income $53 million, EPS $0.88 diluted per share. Guidance reaffirmed.
  - Period: third quarter of 2022
  - Revenue: $620 million
  - Net income: $53 million
  - EPS: $0.88 diluted per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: The Company reported third quarter sales of $620 million, an increase of 2% on a reported basis, and core (excluding Russia) sales of $577 million, or 10% higher core organic growth before currency translation impacts. ESAB also reported third quarter GAAP net income from continuing operations attributable to ESAB of $53 million , $0.88 diluted per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1877322/000187732222000019/0001877322-22-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.